Home
    Disclaimer
    Barbiturates have a narrow therapeutic window and high overdose risk. Combining with alcohol or other depressants can be fatal.

    Phenobarbital

    Aliases: Pheno, Luminal, Solfoton, Phenobarb, Phenobarbitone

    Summary TheDrug.Wiki TripSit PsychonautWiki

    Phenobarbital is a long-acting barbiturate with extremely slow elimination and a narrow therapeutic window. It binds to a distinct allosteric site on GABA-A receptors separate from benzodiazepines, making combinations particularly dangerous as effects potentiate multiplicatively. Tolerance develops rapidly but not to lethal doses, narrowing the safety margin.

    Dose Information TheDrug.Wiki TripSit PsychonautWiki

    ROA Light Common Strong Heavy
    Oral 50-100mg 100-150mg 150-300mg 300mg+
    Light Common Strong Heavy

    Onset, Duration & After-effects TheDrug.Wiki TripSit PsychonautWiki

    ROA Onset Comeup Peak Offset After Effects
    Oral 15-60 min 1-2 hrs 4-6 hrs 12-24 hrs 1-48 hrs
    Intravenous 5 min - 15-30 min 12-24 hrs 1-48 hrs

    Tolerance

    Build-up develops over 1–4 weeks of daily use; hypnotic tolerance faster than anxiolytic tolerance
    Reset weeks to months depending on half-life and duration of use; taper recommended

    Tolerance Decay

    Full tolerance 14d Half tolerance 7d Baseline ~21d

    Tolerance to sedative effects typically builds with regular daily use over 1–2+ weeks and decays slowly over several weeks; data are largely clinical experience and user reports rather than controlled studies. Cross-tolerance with other positive GABAA modulators (e.g., benzodiazepines) is partial but clinically relevant. Because of phenobarbital’s long half-life, perceived tolerance may reflect accumulation rather than receptor-level changes.

    Cross-Tolerances

    Effects Erowid

    Aggregated from 4 Erowid experience reports

    Positive Effects 1

    Anxiety Suppression 100.0% 70%

    Adverse Effects 0

    Combinations TripSit

    Pill Identifiers

    Helpful Links